Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 30671 entries
Sorted by: Best Match Show Resources per page
Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation.

Journal of clinical medicine

Kim YK, Song J.
PMID: 34501267
J Clin Med. 2021 Aug 25;10(17). doi: 10.3390/jcm10173819.

Hepatic encephalopathy is a common complication in patients with liver cirrhosis and portosystemic shunting. Patients with hepatic encephalopathy present a variety of clinical features, including neuropsychiatric manifestations, cognitive dysfunction, impaired gut barrier function, hyperammonemia, and chronic neuroinflammation. These pathogeneses...

Cite
Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173819.
Kim, Y. K., & Song, J. (2021). Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173819
Kim, Young-Kook, and Song, Juhyun. "Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173819
Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med. 2021 Aug 25;10(17). doi: 10.3390/jcm10173819. PMID: 34501267; PMCID: PMC8432232.
Copy Download .nbib Format: NLM
A Rare Case of Coil Migration into the Duodenum after Embolization of a Right Colic Artery Pseudoaneurysm.

Clinical endoscopy

Choi J, Kim YM.
PMID: 33430578
Clin Endosc. 2021 Nov;54(6):920-923. doi: 10.5946/ce.2020.228. Epub 2021 Jan 12.

Transcatheter arterial embolization is a safe and effective treatment for visceral artery aneurysms; nevertheless, some complications can occur. Coil migration to other organs after embolization is extremely rare, and only 16 cases have been reported previously. We report a...

Cite
Choi J, Kim YM. A Rare Case of Coil Migration into the Duodenum after Embolization of a Right Colic Artery Pseudoaneurysm. Clin Endosc. 2021;54(6):920-923doi: 10.5946/ce.2020.228.
Choi, J., & Kim, Y. M. (2021). A Rare Case of Coil Migration into the Duodenum after Embolization of a Right Colic Artery Pseudoaneurysm. Clinical endoscopy, 54(6), 920-923. https://doi.org/10.5946/ce.2020.228
Choi, Jeongmin, and Kim, Young Moon. "A Rare Case of Coil Migration into the Duodenum after Embolization of a Right Colic Artery Pseudoaneurysm." Clinical endoscopy vol. 54,6 (2021): 920-923. doi: https://doi.org/10.5946/ce.2020.228
Choi J, Kim YM. A Rare Case of Coil Migration into the Duodenum after Embolization of a Right Colic Artery Pseudoaneurysm. Clin Endosc. 2021 Nov;54(6):920-923. doi: 10.5946/ce.2020.228. Epub 2021 Jan 12. PMID: 33430578; PMCID: PMC8652176.
Copy Download .nbib Format: NLM
Staged Chest Wall Reconstruction for Radiation-induced Costochondritis.

Plastic and reconstructive surgery. Global open

Kim BS, Kim HI, Kim JI, Park JH, Yi HS, Kim YS, Kim HY.
PMID: 34476146
Plast Reconstr Surg Glob Open. 2021 Aug 05;9(8):e3718. doi: 10.1097/GOX.0000000000003718. eCollection 2021 Aug.

Costochondritis after breast reconstruction and radiation therapy is rarely reported. Moreover, it is difficult to diagnose using computed tomography and magnetic resonance imaging; as such, wound debridement and reconstruction must be performed in several stages. A 51-year-old woman was...

Cite
Kim BS, Kim HI, Kim JI, et al. Staged Chest Wall Reconstruction for Radiation-induced Costochondritis. Plast Reconstr Surg Glob Open. 2021;9(8):e3718doi: 10.1097/GOX.0000000000003718.
Kim, B. S., Kim, H. I., Kim, J. I., Park, J. H., Yi, H. S., Kim, Y. S., & Kim, H. Y. (2021). Staged Chest Wall Reconstruction for Radiation-induced Costochondritis. Plastic and reconstructive surgery. Global open, 9(8), e3718. https://doi.org/10.1097/GOX.0000000000003718
Kim, Byeong Seok, et al. "Staged Chest Wall Reconstruction for Radiation-induced Costochondritis." Plastic and reconstructive surgery. Global open vol. 9,8 (2021): e3718. doi: https://doi.org/10.1097/GOX.0000000000003718
Kim BS, Kim HI, Kim JI, Park JH, Yi HS, Kim YS, Kim HY. Staged Chest Wall Reconstruction for Radiation-induced Costochondritis. Plast Reconstr Surg Glob Open. 2021 Aug 05;9(8):e3718. doi: 10.1097/GOX.0000000000003718. eCollection 2021 Aug. PMID: 34476146; PMCID: PMC8395594.
Copy Download .nbib Format: NLM
Differential expression pattern of novel MADS-box genes in early root formation and differentiation of sweet potato.

Gene expression patterns : GEP

Kim JS, Jang M, Nie H, Lee J, Hong E, Kim SJ, Kim SH.
PMID: 34798351
Gene Expr Patterns. 2021 Nov 17;43:119216. doi: 10.1016/j.gep.2021.119216. Epub 2021 Nov 17.

MADS-box genes are important transcription factors affecting overall development, but their role in sweet potato [Ipomoea batatas (L.) Lam.] has not been fully studied. This study isolated six novel MADS-box genes (IbSOC1, IbFUL1, IbAGL6, IbSVP1, IbSVP2, and IbSVP3) from...

Cite
Kim JS, Jang M, Nie H, et al. Differential expression pattern of novel MADS-box genes in early root formation and differentiation of sweet potato. Gene Expr Patterns. 2021;43:119216doi: 10.1016/j.gep.2021.119216.
Kim, J. S., Jang, M., Nie, H., Lee, J., Hong, E., Kim, S. J., & Kim, S. H. (2021). Differential expression pattern of novel MADS-box genes in early root formation and differentiation of sweet potato. Gene expression patterns : GEP, 43119216. https://doi.org/10.1016/j.gep.2021.119216
Kim, Ji-Seong, et al. "Differential expression pattern of novel MADS-box genes in early root formation and differentiation of sweet potato." Gene expression patterns : GEP vol. 43 (2021): 119216. doi: https://doi.org/10.1016/j.gep.2021.119216
Kim JS, Jang M, Nie H, Lee J, Hong E, Kim SJ, Kim SH. Differential expression pattern of novel MADS-box genes in early root formation and differentiation of sweet potato. Gene Expr Patterns. 2021 Nov 17;43:119216. doi: 10.1016/j.gep.2021.119216. Epub 2021 Nov 17. PMID: 34798351.
Copy Download .nbib Format: NLM
Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection.

Journal of clinical pharmacology

Hwang JG, Kim YK, Choi YS, Kwon SK, Han JH, Park MK.
PMID: 34327707
J Clin Pharmacol. 2022 Jan;62(1):46-54. doi: 10.1002/jcph.1945. Epub 2021 Sep 17.

Per the well-known resistance of hepatitis B virus to nucleoside/nucleotide analogs, alternative treatment options with higher resistance barriers have been approved for use in both treatment-naïve and lamivudine-resistant hepatitis B virus infections. This phase I study was conducted in...

Cite
Hwang JG, Kim YK, Choi YS, et al. Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection. J Clin Pharmacol. 2021;62(1):46-54doi: 10.1002/jcph.1945.
Hwang, J. G., Kim, Y. K., Choi, Y. S., Kwon, S. K., Han, J. H., & Park, M. K. (2022). Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection. Journal of clinical pharmacology, 62(1), 46-54. https://doi.org/10.1002/jcph.1945
Hwang, Jun Gi, et al. "Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection." Journal of clinical pharmacology vol. 62,1 (2022): 46-54. doi: https://doi.org/10.1002/jcph.1945
Hwang JG, Kim YK, Choi YS, Kwon SK, Han JH, Park MK. Influence of Renal Function on the Single-Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection. J Clin Pharmacol. 2022 Jan;62(1):46-54. doi: 10.1002/jcph.1945. Epub 2021 Sep 17. PMID: 34327707.
Copy Download .nbib Format: NLM
Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience.

Circulation journal : official journal of the Japanese Circulation Society

Rhee Y, Kim HJ, Kim JJ, Kim MS, Lee SE, Yun TJ, Lee JW, Jung SH.
PMID: 33867405
Circ J. 2021 Aug 25;85(9):1451-1459. doi: 10.1253/circj.CJ-20-0960. Epub 2021 Apr 16.

BACKGROUND: Since the international consensus on primary graft dysfunction (PGD) following heart transplantation (HT) was reported in 2014, few clinical studies have been reported. We aimed to analyze the incidence, predictive factors, and clinical implications of PGD following the...

Cite
Rhee Y, Kim HJ, Kim JJ, et al. Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience. Circ J. 2021;85(9):1451-1459doi: 10.1253/circj.CJ-20-0960.
Rhee, Y., Kim, H. J., Kim, J. J., Kim, M. S., Lee, S. E., Yun, T. J., Lee, J. W., & Jung, S. H. (2021). Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience. Circulation journal : official journal of the Japanese Circulation Society, 85(9), 1451-1459. https://doi.org/10.1253/circj.CJ-20-0960
Rhee, Younju, et al. "Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience." Circulation journal : official journal of the Japanese Circulation Society vol. 85,9 (2021): 1451-1459. doi: https://doi.org/10.1253/circj.CJ-20-0960
Rhee Y, Kim HJ, Kim JJ, Kim MS, Lee SE, Yun TJ, Lee JW, Jung SH. Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience. Circ J. 2021 Aug 25;85(9):1451-1459. doi: 10.1253/circj.CJ-20-0960. Epub 2021 Apr 16. PMID: 33867405.
Copy Download .nbib Format: NLM
Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement.

Journal of thoracic disease

Kim W, Hwang HY, Kang Y, Kim JS, Sohn SH, Choi JW, Kim KH.
PMID: 34422327
J Thorac Dis. 2021 Jul;13(7):3969-3978. doi: 10.21037/jtd-21-281.

BACKGROUND: This study aimed to compare long-term outcomes, including durability, after bovine pericardial valve replacement with those after porcine mitral valve replacement (MVR).METHODS: We enrolled 309 patients who underwent MV replacement (mean age: 65.8±11.5 years; 68.9% females) with Carpentier-Edwards...

Cite
Kim W, Hwang HY, Kang Y, et al. Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement. J Thorac Dis. 2021;13(7):3969-3978doi: 10.21037/jtd-21-281.
Kim, W., Hwang, H. Y., Kang, Y., Kim, J. S., Sohn, S. H., Choi, J. W., & Kim, K. H. (2021). Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement. Journal of thoracic disease, 13(7), 3969-3978. https://doi.org/10.21037/jtd-21-281
Kim, Woojung, et al. "Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement." Journal of thoracic disease vol. 13,7 (2021): 3969-3978. doi: https://doi.org/10.21037/jtd-21-281
Kim W, Hwang HY, Kang Y, Kim JS, Sohn SH, Choi JW, Kim KH. Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement. J Thorac Dis. 2021 Jul;13(7):3969-3978. doi: 10.21037/jtd-21-281. PMID: 34422327; PMCID: PMC8339742.
Copy Download .nbib Format: NLM
The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology

Horwitz S, O'Connor OA, Pro B, Trümper L, Iyer S, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Menne T, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Zinzani PL, Miao H, Bunn V, Fenton K, Fanale M, Puhlmann M, Illidge T.
PMID: 34921960
Ann Oncol. 2021 Dec 15; doi: 10.1016/j.annonc.2021.12.002. Epub 2021 Dec 15.

BACKGROUND: For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline treatment with CHOP or CHOP-like therapy are typically poor. The ECHELON-2 study demonstrated that brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (A+CHP) exhibited statistically superior progression-free survival (PFS)...

Cite
Horwitz S, O'Connor OA, Pro B, et al. The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Ann Oncol. 2021;doi: 10.1016/j.annonc.2021.12.002.
Horwitz, S., O'Connor, O. A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T., Menne, T., Belada, D., Illés, �. �., Tobinai, K., Tsukasaki, K., Yeh, S. P., Shustov, A., Hüttmann, A., Savage, K. J., Yuen, S., Zinzani, P. L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., & Illidge, T. (2021). The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, et al. "The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology vol. (2021). doi: https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz S, O'Connor OA, Pro B, Trümper L, Iyer S, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Menne T, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Zinzani PL, Miao H, Bunn V, Fenton K, Fanale M, Puhlmann M, Illidge T. The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Ann Oncol. 2021 Dec 15; doi: 10.1016/j.annonc.2021.12.002. Epub 2021 Dec 15. PMID: 34921960.
Copy Download .nbib Format: NLM
Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study.

Journal of Korean medical science

Min J, Ko Y, Kim HW, Koo HK, Oh JY, Jeong YJ, Kang HH, Park KJ, Hwang YI, Kim JW, Ahn JH, Jegal Y, Kang JY, Lee SS, Park JS, Kim JS.
PMID: 35040295
J Korean Med Sci. 2022 Jan 17;37(3):e20. doi: 10.3346/jkms.2022.37.e20.

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused disruptions to healthcare systems, consequently endangering tuberculosis (TB) control. We investigated delays in TB treatment among notified patients during the first wave of the COVID-19 pandemic in Korea.METHODS: We systemically collected...

Cite
Min J, Ko Y, Kim HW, et al. Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study. J Korean Med Sci. 2022;37(3):e20doi: 10.3346/jkms.2022.37.e20.
Min, J., Ko, Y., Kim, H. W., Koo, H. K., Oh, J. Y., Jeong, Y. J., Kang, H. H., Park, K. J., Hwang, Y. I., Kim, J. W., Ahn, J. H., Jegal, Y., Kang, J. Y., Lee, S. S., Park, J. S., & Kim, J. S. (2022). Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study. Journal of Korean medical science, 37(3), e20. https://doi.org/10.3346/jkms.2022.37.e20
Min, Jinsoo, et al. "Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study." Journal of Korean medical science vol. 37,3 (2022): e20. doi: https://doi.org/10.3346/jkms.2022.37.e20
Min J, Ko Y, Kim HW, Koo HK, Oh JY, Jeong YJ, Kang HH, Park KJ, Hwang YI, Kim JW, Ahn JH, Jegal Y, Kang JY, Lee SS, Park JS, Kim JS. Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study. J Korean Med Sci. 2022 Jan 17;37(3):e20. doi: 10.3346/jkms.2022.37.e20. PMID: 35040295.
Copy Download .nbib Format: NLM
Harnessing Chemical Ecology for Environment-Friendly Crop Protection.

Phytopathology

Kang S, Lumactud R, Li N, Bell TH, Kim HS, Park SY, Lee YH.
PMID: 33908803
Phytopathology. 2021 Oct;111(10):1697-1710. doi: 10.1094/PHYTO-01-21-0035-RVW. Epub 2021 Nov 04.

Heavy reliance on synthetic pesticides for crop protection has become increasingly unsustainable, calling for robust alternative strategies that do not degrade the environment and vital ecosystem services. There are numerous reports of successful disease control by various microbes used...

Cite
Kang S, Lumactud R, Li N, et al. Harnessing Chemical Ecology for Environment-Friendly Crop Protection. Phytopathology. 2021;111(10):1697-1710doi: 10.1094/PHYTO-01-21-0035-RVW.
Kang, S., Lumactud, R., Li, N., Bell, T. H., Kim, H. S., Park, S. Y., & Lee, Y. H. (2021). Harnessing Chemical Ecology for Environment-Friendly Crop Protection. Phytopathology, 111(10), 1697-1710. https://doi.org/10.1094/PHYTO-01-21-0035-RVW
Kang, Seogchan, et al. "Harnessing Chemical Ecology for Environment-Friendly Crop Protection." Phytopathology vol. 111,10 (2021): 1697-1710. doi: https://doi.org/10.1094/PHYTO-01-21-0035-RVW
Kang S, Lumactud R, Li N, Bell TH, Kim HS, Park SY, Lee YH. Harnessing Chemical Ecology for Environment-Friendly Crop Protection. Phytopathology. 2021 Oct;111(10):1697-1710. doi: 10.1094/PHYTO-01-21-0035-RVW. Epub 2021 Nov 04. PMID: 33908803.
Copy Download .nbib Format: NLM
Scoping Review of the Literature on Smart Healthcare for Older Adults.

Yonsei medical journal

Ji YA, Kim HS.
PMID: 35040602
Yonsei Med J. 2022 Jan;63:S14-S21. doi: 10.3349/ymj.2022.63.S14.

Smart healthcare systems are being designed to provide medical services to and improve the daily lives of older adults. However, most research has been focused on technical issues, despite a need to conduct in-depth studies on related ethical issues....

Cite
Ji YA, Kim HS. Scoping Review of the Literature on Smart Healthcare for Older Adults. Yonsei Med J. 2022;63:S14-S21doi: 10.3349/ymj.2022.63.S14.
Ji, Y. A., & Kim, H. S. (2022). Scoping Review of the Literature on Smart Healthcare for Older Adults. Yonsei medical journal, 63S14-S21. https://doi.org/10.3349/ymj.2022.63.S14
Ji, Young-A, and Kim, Hun-Sung. "Scoping Review of the Literature on Smart Healthcare for Older Adults." Yonsei medical journal vol. 63 (2022): S14-S21. doi: https://doi.org/10.3349/ymj.2022.63.S14
Ji YA, Kim HS. Scoping Review of the Literature on Smart Healthcare for Older Adults. Yonsei Med J. 2022 Jan;63:S14-S21. doi: 10.3349/ymj.2022.63.S14. PMID: 35040602.
Copy Download .nbib Format: NLM
Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.

Yonsei medical journal

Kim SY, Moon JY, Shin J, Sim JY, Kim M, Jang J.
PMID: 35040606
Yonsei Med J. 2022 Jan;63:S56-S62. doi: 10.3349/ymj.2022.63.S56.

PURPOSE: This study was conducted to build a direction for government policies regarding strategies for the commercialization of digital therapeutics in Korea, as well as its globalization.MATERIALS AND METHODS: The study included 37 participants from the Korea Digital Health...

Cite
Kim SY, Moon JY, Shin J, et al. Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics. Yonsei Med J. 2022;63:S56-S62doi: 10.3349/ymj.2022.63.S56.
Kim, S. Y., Moon, J. Y., Shin, J., Sim, J. Y., Kim, M., & Jang, J. (2022). Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics. Yonsei medical journal, 63S56-S62. https://doi.org/10.3349/ymj.2022.63.S56
Kim, Soo Young, et al. "Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics." Yonsei medical journal vol. 63 (2022): S56-S62. doi: https://doi.org/10.3349/ymj.2022.63.S56
Kim SY, Moon JY, Shin J, Sim JY, Kim M, Jang J. Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics. Yonsei Med J. 2022 Jan;63:S56-S62. doi: 10.3349/ymj.2022.63.S56. PMID: 35040606.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 30671 entries